{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:51:46Z","timestamp":1793235106978,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,5,3]],"date-time":"2012-05-03T00:00:00Z","timestamp":1336003200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1475-2875-11-153","type":"journal-article","created":{"date-parts":[[2012,5,3]],"date-time":"2012-05-03T14:22:11Z","timestamp":1336054931000},"source":"Crossref","is-referenced-by-count":28,"title":["Efficacy and safety of artemisinin-naphthoquine versus dihydroartemisinin-piperaquine in adult patients with uncomplicated malaria: a multi-centre study in Indonesia"],"prefix":"10.1186","volume":"11","author":[{"name":"Nurhayati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiliana","family":"Tjitra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Trihono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armedy R","family":"Hasugian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadjar","family":"Siswantoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Budi","family":"Prasetyorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riyanti","family":"Ekowatiningsih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Endah A","family":"Yusnita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Telly","family":"Purnamasari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srilaning","family":"Driyah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ervi","family":"Salwati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eni","family":"Yuwarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidwina","family":"Januar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Labora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bambang","family":"Wijayanto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fajar","family":"Amansyah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tersila AD","family":"Dedang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asep","family":"Purnama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,5,3]]},"reference":[{"key":"2099_CR1","volume-title":"World Malaria Report 2008. WHO\/HTM\/GMP\/2008.1","author":"World Health Organization","year":"2008","unstructured":"World Health Organization: World Malaria Report 2008. WHO\/HTM\/GMP\/2008.1. 2008, WHO, Geneva"},{"key":"2099_CR2","volume-title":"Antimalarial drug combination therapy","author":"World Health Organization","year":"2001","unstructured":"World Health Organization: Antimalarial drug combination therapy. 2001, WHO, Geneva"},{"key":"2099_CR3","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1016\/S0140-6736(96)91488-9","volume":"347","author":"RN Price","year":"1996","unstructured":"Price RN, Nosten F, Luxemburger C, Ter Kuile FO, Paiphun L, Chongsuphajaisiddhi T, White NJ: Effects of artemisinin derivatives on malaria transmissibility. Lancet. 1996, 347: 1654-1658. 10.1016\/S0140-6736(96)91488-9.","journal-title":"Lancet"},{"key":"2099_CR4","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0140-6736(00)02505-8","volume":"356","author":"F Nosten","year":"2000","unstructured":"Nosten F, van Vugt M, Price RN, Luxemburger C, Thway KL, Brockman A, McGready R, ter Kuile F, Looareesuwan S, White NJ: Effects of artesunate-mefloquine combination on incidence ofPlasmodium falciparummalaria and mefloquine resistance in western Thailand: a prospective study. Lancet. 2000, 356: 297-302. 10.1016\/S0140-6736(00)02505-8.","journal-title":"Lancet"},{"key":"2099_CR5","first-page":"27","volume":"25","author":"E Tjitra","year":"1997","unstructured":"Tjitra E, Gunawan S, Laihad F, Marwoto H, Sulaksono S, Arjoso S, Richie TL, Manurung N: Evaluation of antimalaria drugs in Indonesia, 1981\u20131995. Bull Hlth Studies. 1997, 25: 27-58.","journal-title":"Bull Hlth Studies"},{"key":"2099_CR6","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1086\/512677","volume":"44","author":"AR Hasugian","year":"2007","unstructured":"Hasugian AR, Purba HLE, Kenangalem E, Wuwung RM, Ebsworth EP, Maristela R, Penttinen PMP, Laihad F, Anstey NM, Tjitra E, Price RN: Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistantPlasmodium falciparumandPlasmodium vivaxmalaria. Clin Infect Dis. 2007, 44: 1067-1074. 10.1086\/512677.","journal-title":"Clin Infect Dis"},{"key":"2099_CR7","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S0140-6736(07)60160-3","volume":"369","author":"A Ratcliff","year":"2007","unstructured":"Ratcliff A, Siswantoro H, Kenangalem E, Maristela R, Wuwung RM, Laihad F, Ebsworth EP, Anstey NM, Tjitra E, Price RN: Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison. Lancet. 2007, 369: 757-765. 10.1016\/S0140-6736(07)60160-3.","journal-title":"Lancet"},{"key":"2099_CR8","first-page":"20","volume":"17","author":"X Pang","year":"1999","unstructured":"Pang X, Wang G, Xing Q: Hundred one casesPlasmodium falciparumtreated with naphthoquine phosphate. Chinese J Parasitic Disease. 1999, 17: 20-22.","journal-title":"Chinese J Parasitic Disease"},{"key":"2099_CR9","first-page":"135","volume":"16","author":"JY Wang","year":"2003","unstructured":"Wang JY, Shan CQ, Fu D: Clinical trial of co-naphthoquine in the treatment of falciparum malaria. Chin J Parasit Dis Con. 2003, 16: 135-136.","journal-title":"Chin J Parasit Dis Con"},{"key":"2099_CR10","first-page":"235","volume":"17","author":"WZ Guo","year":"2003","unstructured":"Guo WZ, Zheng Q, Li G, Guo XB: A randomized controlled study of napthoquine and artesunate in the treatment of falciparum malaria. Journal of Guangzhou University Traditional Chinese Medicine. 2003, 17: 235-237.","journal-title":"Journal of Guangzhou University Traditional Chinese Medicine"},{"key":"2099_CR11","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.actatropica.2003.11.008","volume":"89","author":"JY Wang","year":"2004","unstructured":"Wang JY, Cao W, Shan CQ, Zhang M, Li GF, Ding DB, Shi YL, Wu BA, AMMS China: Naphthoquine phosphate and its combination with artemisinin. Acta Trop. 2004, 89: 375-381. 10.1016\/j.actatropica.2003.11.008.","journal-title":"Acta Trop"},{"key":"2099_CR12","volume-title":"Guidelines for the treatment of malaria. WHO\/HTM\/MAL\/2006.1108","author":"World Health Organization","year":"2006","unstructured":"World Health Organization: Guidelines for the treatment of malaria. WHO\/HTM\/MAL\/2006.1108. 2006, WHO, Geneva"},{"key":"2099_CR13","volume-title":"The Lancet Handbook of Essential Concepts in Clinical Research. Main edition","author":"KF Schulz","year":"2006","unstructured":"Schulz KF, Grimes DA: The Lancet Handbook of Essential Concepts in Clinical Research. Main edition. 2006, Elsevier, Edinburg, London, New York, Oxford, Philadelphia, St Louis, Sydney, Toronto"},{"key":"2099_CR14","volume-title":"Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria","author":"World Health Organization","year":"2003","unstructured":"World Health Organization: Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. 2003, WHO, Geneva"},{"key":"2099_CR15","volume-title":"Methods and techniques for clinical trials on antimalarial drug efficacy. Genotyping to identify parasite populations. Informal consultation organized by the Medicines for Malaria Venture and cosponsored by the World Health Organization. 29\u201331 May 2007","author":"World Health Organization","year":"2008","unstructured":"World Health Organization: Methods and techniques for clinical trials on antimalarial drug efficacy. Genotyping to identify parasite populations. Informal consultation organized by the Medicines for Malaria Venture and cosponsored by the World Health Organization. 29\u201331 May 2007. 2008, WHO, Amsterdam, The Netherlands"},{"key":"2099_CR16","doi-asserted-by":"publisher","first-page":"c2697","DOI":"10.1136\/bmj.c2697","volume":"340","author":"I Abraha","year":"2010","unstructured":"Abraha I, Montedori A: Modified intention to treat reporting in randomized controlled trials: systematic review. BMJ. 2010, 340: c2697-10.1136\/bmj.c2697. Epub 2010\/06\/16","journal-title":"BMJ"},{"key":"2099_CR17","volume-title":"Toxicity Grading Scale for Determining Severity of Adverse Events","author":"Monitoring and Reporting Adverse Events. World Health Organization","year":"2003","unstructured":"Monitoring and Reporting Adverse Events. World Health Organization: Toxicity Grading Scale for Determining Severity of Adverse Events. 2003, , , [\n                    http:\/\/icssc.org\/documents\/AE%20Manual%202003%20Appendices%20February_06_2003%20final.pdf\n                    \n                  ]"},{"key":"2099_CR18","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/S0140-6736(02)08348-4","volume":"359","author":"M Adjuik","year":"2002","unstructured":"Adjuik M, Agnamey P, Babiker A, Borrmann S, Brasseur P, Cisse M, Cobelens F, Diallo S, Faucher JF, Garner P, Gikunda S, Kremsner PG, Krishna S, Lell B, Loolpapit M, Matsiegui PB, Missinou MA, Mwanza J, Ntoumi F, Olliaro P, Osimbo P, Rezbach P, Some E, Taylor WRJ: Amodiaquine-artesunate versus amodiaquine for uncomplicatedPlasmodium falciparummalaria in African children: a randomised, multicentre trial. Lancet. 2002, 359: 1365-1372. 10.1016\/S0140-6736(02)08348-4.","journal-title":"Lancet"},{"key":"2099_CR19","volume-title":"The use of artemisinin and its derivatives as antimalarial drugs: report of a joint CTD\/DMP\/TDR Informal Consultation, WHO\/MAL\/98.1086","author":"World Health Organization","year":"1998","unstructured":"World Health Organization: The use of artemisinin and its derivatives as antimalarial drugs: report of a joint CTD\/DMP\/TDR Informal Consultation, WHO\/MAL\/98.1086. 1998, WHO, Geneva"},{"key":"2099_CR20","doi-asserted-by":"publisher","first-page":"14216","DOI":"10.1073\/pnas.0804628105","volume":"105","author":"MF Boni","year":"2008","unstructured":"Boni MF, Smith DL, Laxminarayan R: Benefits of using multiple first-line therapies. Proc Natl Acad Sci USA. 2008, 105: 14216-14221. 10.1073\/pnas.0804628105.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2099_CR21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4269\/ajtmh.2005.72.163","volume":"72","author":"WM Watkins","year":"2005","unstructured":"Watkins WM, Sibley CH, Hastings IM: The search for effective and sustainable treatment forPlasmodium falciparummalaria in Africa: a model of the selection of resistance by antifolate drugs and their combinations. AmJTrop Med Hyg. 2005, 72: 163-173.","journal-title":"AmJTrop Med Hyg"},{"key":"2099_CR22","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.actatropica.2009.05.007","volume":"111","author":"T Tun","year":"2009","unstructured":"Tun T, Tint HS, Lin K, Kyaw TT, Myint MK, Khaing W, Tun ZW: Efficacy of oral single dose therapy with artemisinin\u2013naphthoquine phosphate in uncomplicated falciparum malaria. Acta Trop. 2009, 111: 275-278. 10.1016\/j.actatropica.2009.05.007.","journal-title":"Acta Trop"},{"key":"2099_CR23","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/1475-2875-8-196","volume":"8","author":"FW Hombhanje","year":"2009","unstructured":"Hombhanje FW, Linge D, Saweri A, Kuanch C, Jones R, Toraso S, Geita J, Masta A, Kevau I, Hiawalyer G, Sapuri M: Artemisinin-naphthoquine combination (ARCOTM) therapy for uncomplicated falciparum malaria in adults of Papua New Guinea: a preliminary report on safety and efficacy. Malar J. 2009, 8: 196-10.1186\/1475-2875-8-196.","journal-title":"Malar J"},{"key":"2099_CR24","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1086\/344647","volume":"35","author":"MB Denis","year":"2002","unstructured":"Denis MB, Davis TM, Hewitt S, Incardona S, Nimol K, Fandeur T, Poravuth Y, Lim C, Socheat D: Efficacy and safety of dihydroartemisinin-piperaquine (Artekin) in Cambodian children and adults with uncomplicated falciparum malaria. Clin Infect Dis. 2002, 35: 1469-1476. 10.1086\/344647.","journal-title":"Clin Infect Dis"},{"key":"2099_CR25","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S0140-6736(03)15163-X","volume":"363","author":"TH Tran","year":"2004","unstructured":"Tran TH, Dolecek C, Pham PM, Nguyen TD, Nguyen TT, Le HT, Dong THA, Tran TT, Stepniewska K, White NJ, Farrar J: Dihydroartemisinin-piperaquine against multidrug-resistantPlasmodium falciparummalaria in Vietnam: randomized clinical trial. Lancet. 2004, 363: 18-22. 10.1016\/S0140-6736(03)15163-X.","journal-title":"Lancet"},{"key":"2099_CR26","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1086\/425015","volume":"190","author":"EA Ashley","year":"2004","unstructured":"Ashley EA, Krudsood S, Phaiphun L, Srivilairit S, McGready R, Leowattana W, Hutagalung R, Wilairatana P, Brockman A, Looareesuwan S, Nosten F, White NJ: Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand. J Infect Dis. 2004, 190: 1773-1782. 10.1086\/425015.","journal-title":"J Infect Dis"},{"key":"2099_CR27","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1016\/S0140-6736(06)68931-9","volume":"367","author":"F Smithuis","year":"2006","unstructured":"Smithuis F, Kyaw MK, Phe O, Win T, Aung PP, Oo APP, Naing AL, Nyo MY, Myint NZH, Imwong M, Ashley E, Lee SJ, White NJ: Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria an open-label randomized comparison. Lancet. 2006, 367: 2075-2085. 10.1016\/S0140-6736(06)68931-9.","journal-title":"Lancet"},{"key":"2099_CR28","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1111\/j.1365-3156.2006.01671.x","volume":"11","author":"M Mayxay","year":"2006","unstructured":"Mayxay M, Thongpraseuth V, Khanthavong M, Lindegardh N, Barends M, Keola S, Pongvongsa T, Phompida S, Phetsouvanh R, Stepniewska K, White NJ, Newton PN: An open, randomized comparison of artesunate plus mefloquine vs dihydroartemisinin-piperaquine for the treatment of uncomplicatedPlasmodium falciparummalaria in the Lao People\u2019s Democratic Republic (Laos). Trop Med Int Health. 2006, 11: 1157-1165. 10.1111\/j.1365-3156.2006.01671.x.","journal-title":"Trop Med Int Health"},{"key":"2099_CR29","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/0001-706X(91)90052-L","volume":"48","author":"TM Davis","year":"1991","unstructured":"Davis TM, Ho M, Supanaranond W, Looareesuwan S, Pukrittayakamee S, White NJ: Changes in the peripheral blood eosinophil count in falciparum malaria. Acta Trop. 1991, 48: 243-246. 10.1016\/0001-706X(91)90052-L.","journal-title":"Acta Trop"},{"key":"2099_CR30","first-page":"795","volume":"23","author":"GD Shanks","year":"1992","unstructured":"Shanks GD, Wilairatanaporn C: Eosinophilic response to falciparum malaria infections. Southeast Asian J Trop Med Public Health. 1992, 23: 795-797.","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"2099_CR31","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1007\/s00277-004-0987-z","volume":"84","author":"J Huh","year":"2005","unstructured":"Huh J, Jung J, Yoon H, Chung W: Pseudoeosinophilia associated with malaria infection determined in the Sysmex XE-2100 hematology analyzer. Ann Hematol. 2005, 84: 400-402. 10.1007\/s00277-004-0987-z.","journal-title":"Ann Hematol"},{"key":"2099_CR32","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00277-008-0486-8","volume":"87","author":"HJ Huh","year":"2008","unstructured":"Huh HJ, Oh GY, Huh JW, Chae SL: Malaria detection with the Sysmex XE-2100 hematology analyzer using pseudoeosinophilia and abnormal WBC scattergram. Ann Hematol. 2008, 87: 755-759. 10.1007\/s00277-008-0486-8.","journal-title":"Ann Hematol"},{"key":"2099_CR33","first-page":"131","volume":"21","author":"JY Wang","year":"2003","unstructured":"Wang JY, Sun ZW, Fu DD: Efficacy of naphthoquine, artemisinin and combination of the two drugs in the treatment of falciparum malaria. Clin J Parasitic Dis. 2003, 21: 131-133.","journal-title":"Clin J Parasitic Dis"},{"key":"2099_CR34","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/1475-2875-8-148","volume":"8","author":"OA Toure","year":"2009","unstructured":"Toure OA, Penali LK, Yapi JD, Ako BA, Toure W, Djerea K, Gomez GO, Makaila O: A comparative, randomized clinical trial of artemisinin\/naphtoquine twice daily one dayversusartemether\/lumefantrine six doses regimen in children and adults with uncomplicated falciparum malaria in C\u00f4te d\u2019Ivoire. Malar J. 2009, 8: 148-10.1186\/1475-2875-8-148.","journal-title":"Malar J"},{"key":"2099_CR35","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1128\/AAC.06248-11","volume":"56","author":"J Benyamin","year":"2012","unstructured":"Benyamin J, Moore B, Lee ST, Senn M, Griffin S, Lautu D, Salman S, Siba P, Mueller I, Davis TM: Artemisinin-naphthoquine combination therapy for uncomplicated pediatric malaria: a tolerability, safety, and preliminary efficacy study. Antimicrob Agents Chemother. 2012, 56: 2465-2471. 10.1128\/AAC.06248-11.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2875-11-153.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1475-2875-11-153\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2875-11-153.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T10:50:39Z","timestamp":1548240639000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/1475-2875-11-153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,3]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["2099"],"URL":"https:\/\/doi.org\/10.1186\/1475-2875-11-153","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,3]]},"article-number":"153"}}